Cardiovascular health for patients with psoriasis: a précis for front-line clinicians

Daniel G Federman1, Michael L Shelling, Srdjan Prodanovich

  • 1Department of Medicine, VA Connecticut Health Care, West Haven, Connecticut 06516, USA. daniel.federman@va.gov

Insights

Psoriasis patients face higher cardiovascular risks, including heart attack, even without typical risk factors. Early evaluation and management of these risks are crucial for better patient outcomes.

Area of Science:

  • Immunology
  • Cardiology
  • Dermatology

Background:

  • Psoriasis is a common immune disorder affecting skin and joints, impacting quality of life.
  • Psoriasis is linked to increased prevalence of cardiovascular risk factors like hypertension, diabetes, obesity, smoking, and dyslipidemia.
  • Patients with psoriasis exhibit an elevated risk of myocardial infarction, independent of traditional cardiovascular risk factors.

Purpose of the Study:

  • To raise awareness among dermatologists and primary care providers about the cardiovascular risks associated with psoriasis.
  • To emphasize the importance of evaluating and managing cardiovascular risk factors in psoriasis patients.
  • To improve the cardiovascular health outcomes for individuals with psoriasis.

Main Methods:

  • This is a review article, synthesizing existing research on psoriasis and cardiovascular disease.
  • The review focuses on observational studies and clinical data linking psoriasis to cardiovascular outcomes.
  • Key cardiovascular risk factors and their association with psoriasis severity are examined.

Main Results:

  • Patients with psoriasis demonstrate a higher incidence of cardiovascular risk factors.
  • An increased risk of myocardial infarction is observed in psoriasis patients, irrespective of other risk factors.
  • Severe psoriasis is associated with increased mortality rates compared to the general population.

Conclusions:

  • Psoriasis is significantly associated with cardiovascular disease and increased mortality.
  • Healthcare providers should proactively screen and manage cardiovascular risks in psoriasis patients.
  • Addressing cardiovascular comorbidities is essential for comprehensive psoriasis management and improved patient survival.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...